Biogen, Inc.:戦略・SWOT・企業財務分析

MarketLineが発行した調査報告書(DATA8014725)
◆英語タイトル:Biogen, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8014725
◆発行会社(リサーチ会社):MarketLine
◆発行日:2017年11月13日
◆ページ数:60
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥18,375見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,750見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥55,125見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。MarketLine社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Biogen, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Biogen, Inc. (or ‘the company’), formerly known as Biogen Idec, is a biopharmaceutical company engaged in the discovery, development, manufacturing, and commercialization of therapies in the areas of hematology, neurology and immunology. The company’s key products include Tecfidera, Tysabri (natalizumab), Avonex (Interferon beta-1a) and Rituxan (rituximab). The company primarily operates in the US and Europe. It is headquartered in Weston, Massachusetts and employed about 7,350 people as of December 31, 2015.

Scope

- Detailed information on Biogen, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Biogen, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Biogen, Inc. including a breakdown and examination of key business segments
- Intelligence on Biogen, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Biogen, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Biogen, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Biogen, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Biogen, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Biogen, Inc.: Company Overview
Biogen, Inc.: Overview and Key Facts
Biogen, Inc.: Overview
Biogen, Inc.: Key Facts
Biogen, Inc.: Key Employees
Biogen, Inc.: Key Employee Biographies
Biogen, Inc.: Major Products and Services
Biogen, Inc.: Company History
Biogen, Inc.: Management Statement
Biogen, Inc.: Key Competitors
Biogen, Inc.: Company Analysis
Biogen, Inc.: Business Description
Biogen, Inc.: SWOT Analysis
Biogen, Inc.: SWOT Overview
Biogen, Inc.: Strengths
Biogen, Inc.: Weaknesses
Biogen, Inc.: Opportunities
Biogen, Inc.: Threats
Biogen, Inc.: Corporate Financial Deals Activity
Biogen, Inc.: Financial Deals Overview
Biogen, Inc.: Targets and Partners
Biogen, Inc.: Top Deals 2013 – 2017YTD*
Biogen, Inc.: Mergers and Acquisitions
Biogen, Inc.: Corporate Venturing
Biogen, Inc.: Partnership
Biogen, Inc.: Recent Developments
Biogen, Inc.: News and Events Summary
Biogen, Inc.: Business Expansion
Biogen, Inc.: Contracts
Biogen, Inc.: Corporate Social Responsibility
Biogen, Inc.: Financial Performance
Biogen, Inc.: Market Developments
Biogen, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Biogen, Inc.: Key Facts
Table 2: Biogen, Inc.: Key Employees
Table 3: Biogen, Inc.: Key Competitors
Table 4: Biogen, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 5: Biogen, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 6: Biogen, Inc.: M&A Average Deal Size - Value (US$m)
Table 7: Biogen, Inc.: Targets and Partners
Table 8: Biogen, Inc.: Top Deals 2013 - 2017YTD*
Table 9: Biogen, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 10: Biogen, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 11: Biogen, Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 12: Biogen, Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 13: Biogen, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 14: Biogen, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 15: Biogen, Inc.: News and Events Summary
Table 16: Biogen, Inc.: Business Expansion
Table 17: Biogen, Inc.: Contracts
Table 18: Biogen, Inc.: Corporate Social Responsibility
Table 19: Biogen, Inc.: Financial Performance
Table 20: Biogen, Inc.: Market Developments
Table 21: Biogen, Inc.: Strategy and Operations

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ Biogen, Inc.:戦略・SWOT・企業財務分析(Biogen, Inc. - Strategy, SWOT and Corporate Finance Report)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆